Zilretta
Payments companies reported to CMS as associated with Zilretta. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Zilretta, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Zilretta
These are the largest totals companies reported as associated with Zilretta. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Mark Kronenfeld | Brooklyn, NY | Anesthesiology | $175,644.46 |
| Nirav Amin | Placentia, CA | Orthopaedic Surgery | $169,604.61 |
| Michael Mont | Baltimore, MD | Adult Reconstructive Orthopaedic Surgery | $160,504.30 |
| Andrew Spitzer | Los Angeles, CA | Orthopaedic Surgery | $141,705.40 |
| Vinod Dasa | Kenner, LA | Orthopaedic Surgery | $118,626.87 |
| Mark Froimson | Cleveland, OH | Orthopaedic Surgery | $83,346.14 |
| Gary Schwartz | Brooklyn, NY | Pain Medicine (Anesthesiology) | $71,124.24 |
| Ali Guermazi | West Roxbury, MA | Diagnostic Radiology | $65,802.85 |
| Christopher Varacallo | Du Bois, PA | Family Medicine | $64,454.79 |
| Karina Gritsenko | Bronx, NY | Anesthesiology | $58,160.48 |
Prescribed Zilretta?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.